These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

537 related items for PubMed ID: 31635804

  • 1. lncRNA OSER1-AS1 acts as a ceRNA to promote tumorigenesis in hepatocellular carcinoma by regulating miR-372-3p/Rab23 axis.
    Fan J, Zhang J, Huang S, Li P.
    Biochem Biophys Res Commun; 2020 Jan 01; 521(1):196-203. PubMed ID: 31635804
    [Abstract] [Full Text] [Related]

  • 2. Long noncoding RNA ZFPM2-AS1 regulates ITGB1 by miR-1226-3p to promote cell proliferation and invasion in hepatocellular carcinoma.
    Liu W, Zhang GQ, Zhu DY, Wang LJ, Li GT, Xu JG, Jin XL, Zhu YM, Yang XY.
    Eur Rev Med Pharmacol Sci; 2020 Jul 01; 24(14):7612-7620. PubMed ID: 32744687
    [Abstract] [Full Text] [Related]

  • 3. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y, Yang L, Chen T, Liu X, Guo Y, Zhu Q, Tong X, Yang W, Xu Q, Huang D, Tu K.
    Mol Cancer; 2019 Feb 19; 18(1):28. PubMed ID: 30782188
    [Abstract] [Full Text] [Related]

  • 4. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
    Bao J, Chen X, Hou Y, Kang G, Li Q, Xu Y.
    Biomed Pharmacother; 2018 Nov 19; 107():824-833. PubMed ID: 30142544
    [Abstract] [Full Text] [Related]

  • 5. The long non-coding RNA ASMTL-AS1 promotes hepatocellular carcinoma progression by sponging miR-1343-3p that suppresses LAMC1 (laminin subunit gamma 1).
    Mou Y, Sun Q.
    Bioengineered; 2022 Jan 19; 13(1):746-758. PubMed ID: 34859735
    [Abstract] [Full Text] [Related]

  • 6. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
    He H, Wang Y, Ye P, Yi D, Cheng Y, Tang H, Zhu Z, Wang X, Jin S.
    J Exp Clin Cancer Res; 2020 Aug 14; 39(1):159. PubMed ID: 32795316
    [Abstract] [Full Text] [Related]

  • 7. Long non-coding RNA CCDC183-AS1 acts AS a miR-589-5p sponge to promote the progression of hepatocellular carcinoma through regulating SKP1 expression.
    Zhu H, Zhang H, Pei Y, Liao Z, Liu F, Su C, Liu Y, Dong R, Song J, Zhang X, Fan Y, Liang H, Zhang B, Chen X.
    J Exp Clin Cancer Res; 2021 Feb 04; 40(1):57. PubMed ID: 33541391
    [Abstract] [Full Text] [Related]

  • 8. C1QTNF1-AS1 regulates the occurrence and development of hepatocellular carcinoma by regulating miR-221-3p/SOCS3.
    Li H, Zhang B, Ding M, Lu S, Zhou H, Sun D, Wu G, Gan X.
    Hepatol Int; 2019 May 04; 13(3):277-292. PubMed ID: 31069760
    [Abstract] [Full Text] [Related]

  • 9. LncRNA TMPO-AS1 promotes hepatocellular carcinoma cell proliferation, migration and invasion through sponging miR-329-3p to stimulate FOXK1-mediated AKT/mTOR signaling pathway.
    Guo X, Wang Y.
    Cancer Med; 2020 Jul 04; 9(14):5235-5246. PubMed ID: 32462698
    [Abstract] [Full Text] [Related]

  • 10. Long non-coding RNA ZEB1-AS1 promotes proliferation and metastasis of hepatocellular carcinoma cells by targeting miR-299-3p/E2F1 axis.
    Mu B, Lv C, Liu Q, Yang H.
    J Biochem; 2021 Sep 22; 170(1):41-50. PubMed ID: 33788950
    [Abstract] [Full Text] [Related]

  • 11. Long noncoding RNA HAND2-AS1 reduced the viability of hepatocellular carcinoma via targeting microRNA-300/SOCS5 axis.
    Bi HQ, Li ZH, Zhang H.
    Hepatobiliary Pancreat Dis Int; 2020 Dec 22; 19(6):567-574. PubMed ID: 32224127
    [Abstract] [Full Text] [Related]

  • 12. LncRNA SNHG14 aggravates invasion and migration as ceRNA via regulating miR-656-3p/SIRT5 pathway in hepatocellular carcinoma.
    Tang SJ, Yang JB.
    Mol Cell Biochem; 2020 Oct 22; 473(1-2):143-153. PubMed ID: 32607966
    [Abstract] [Full Text] [Related]

  • 13. RNF185-AS1 promotes hepatocellular carcinoma progression through targeting miR-221-5p/integrin β5 axis.
    Huang C, Li K, Huang R, Zhu J, Yang J.
    Life Sci; 2021 Feb 15; 267():118928. PubMed ID: 33358902
    [Abstract] [Full Text] [Related]

  • 14. LncRNA KTN1-AS1 promotes tumor growth of hepatocellular carcinoma by targeting miR-23c/ERBB2IP axis.
    Zhang L, Wang L, Wang Y, Chen T, Liu R, Yang W, Liu Q, Tu K.
    Biomed Pharmacother; 2019 Jan 15; 109():1140-1147. PubMed ID: 30551364
    [Abstract] [Full Text] [Related]

  • 15. The long noncoding RNA OTUD6B-AS1 enhances cell proliferation and the invasion of hepatocellular carcinoma cells through modulating GSKIP/Wnt/β-catenin signalling via the sequestration of miR-664b-3p.
    Kong S, Xue H, Li Y, Li P, Ma F, Liu M, Li W.
    Exp Cell Res; 2020 Oct 01; 395(1):112180. PubMed ID: 32682012
    [Abstract] [Full Text] [Related]

  • 16. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
    Li Y, Liu G, Li X, Dong H, Xiao W, Lu S.
    Biochem Biophys Res Commun; 2018 Sep 18; 503(4):2826-2832. PubMed ID: 30115383
    [Abstract] [Full Text] [Related]

  • 17. LncRNA DCST1-AS1 functions as a competing endogenous RNA to regulate FAIM2 expression by sponging miR-1254 in hepatocellular carcinoma.
    Chen J, Wu D, Zhang Y, Yang Y, Duan Y, An Y.
    Clin Sci (Lond); 2019 Jan 31; 133(2):367-379. PubMed ID: 30617187
    [Abstract] [Full Text] [Related]

  • 18. Potential of C1QTNF1-AS1 regulation in human hepatocellular carcinoma.
    Han W, Yu G, Meng X, Hong H, Zheng L, Wu X, Zhang D, Yan B, Ma Y, Li X, Wang Q.
    Mol Cell Biochem; 2019 Oct 31; 460(1-2):37-51. PubMed ID: 31222560
    [Abstract] [Full Text] [Related]

  • 19. ZSCAN16-AS1 expedites hepatocellular carcinoma progression via modulating the miR-181c-5p/SPAG9 axis to activate the JNK pathway.
    Liu J, Liu R, Liu Y, Li L, Cao H, Liu J, Cao G.
    Cell Cycle; 2021 Jun 31; 20(12):1134-1146. PubMed ID: 34097562
    [Abstract] [Full Text] [Related]

  • 20. Long noncoding RNA FOXD2-AS1 aggravates hepatocellular carcinoma tumorigenesis by regulating the miR-206/MAP3K1 axis.
    Hu W, Feng H, Xu X, Huang X, Huang X, Chen W, Hao L, Xia W.
    Cancer Med; 2020 Aug 31; 9(15):5620-5631. PubMed ID: 32558350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.